Article
Enhanced Cytotoxicity against Cholangiocarcinoma by Fifth-Generation Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 and Secreting Anti-PD-L1 scFv
2024-12-17
Abstract excerpt
<title>Abstract</title> <p>Cholangiocarcinoma (CCA) is a fatal bile duct cancer with high resistance and recurrence rates, with only one fifth of patients eligible for surgical treatment. The disease resists standard chemotherapy and often relapses. Chimeric antigen receptor (CAR) T cell therapy has shown promise for hematological malignancies but faces challenges in solid tumors due to resistance mechanisms like...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fea531f-9cae-58d5-8deb-31cfe569d0d2
- DOI
- 10.21203/rs.3.rs-5355014/v1
